<i>Cupriavidus necator</i>-Produced Polyhydroxybutyrate/Eudragit FS Hybrid Nanoparticles Mitigates Ulcerative Colitis via Colon-Targeted Delivery of Cyclosporine A

Polyhydroxybutyrate (PHB) has emerged as a novel material for replacing various plastics used in the medical field. However, its application as a drug-delivery carrier for colitis-targeted delivery has not been explored. In this study, we used biosynthesized PHB combined with Eudragit FS (EFS) and c...

Full description

Bibliographic Details
Main Authors: Juho Lee, Aruzhan Saparbayeva, Shwe Phyu Hlaing, Dongmin Kwak, Hyunwoo Kim, Jihyun Kim, Eun Hee Lee, Jin-Wook Yoo
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/12/2811
_version_ 1797455745133838336
author Juho Lee
Aruzhan Saparbayeva
Shwe Phyu Hlaing
Dongmin Kwak
Hyunwoo Kim
Jihyun Kim
Eun Hee Lee
Jin-Wook Yoo
author_facet Juho Lee
Aruzhan Saparbayeva
Shwe Phyu Hlaing
Dongmin Kwak
Hyunwoo Kim
Jihyun Kim
Eun Hee Lee
Jin-Wook Yoo
author_sort Juho Lee
collection DOAJ
description Polyhydroxybutyrate (PHB) has emerged as a novel material for replacing various plastics used in the medical field. However, its application as a drug-delivery carrier for colitis-targeted delivery has not been explored. In this study, we used biosynthesized PHB combined with Eudragit FS (EFS) and cyclosporine A (CSA) to develop pH-responsive controlled CSA-releasing nanoparticles (CSA-PENPs) for colitis-targeted drug delivery and demonstrated its enhanced therapeutic efficacy in a dextran sulfate sodium (DSS)-induced murine colitis model. PHB was successfully biosynthesized in the bacterium <i>Cupriavidus necator</i>, as demonstrated by <sup>1</sup>H-NMR and FT-IR analyses. CSA-PENPs were fabricated via the oil-in-water emulsion solvent evaporation method. Owing to the potent pH-responsive and sustained drug release properties provided by PHB and EFS, CSA-PENPs could deliver a sufficient amount of CSA to inflamed tissues in the distal colon; in contrast, CSA-loaded EFS nanoparticles displayed premature burst release before reaching the target site. Due to enhanced CSA delivery to colitis tissues, CSA-PENPs exhibited potent anti-inflammatory effects in the DSS-induced murine colitis model. Overall, CSA-PENPs could be a promising drug-delivery system for treating ulcerative colitis.
first_indexed 2024-03-09T15:58:44Z
format Article
id doaj.art-cc2915805ab0466bbc51c00ff5c96d34
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T15:58:44Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-cc2915805ab0466bbc51c00ff5c96d342023-11-24T17:22:27ZengMDPI AGPharmaceutics1999-49232022-12-011412281110.3390/pharmaceutics14122811<i>Cupriavidus necator</i>-Produced Polyhydroxybutyrate/Eudragit FS Hybrid Nanoparticles Mitigates Ulcerative Colitis via Colon-Targeted Delivery of Cyclosporine AJuho Lee0Aruzhan Saparbayeva1Shwe Phyu Hlaing2Dongmin Kwak3Hyunwoo Kim4Jihyun Kim5Eun Hee Lee6Jin-Wook Yoo7College of Pharmacy, Pusan National University, Busan 46241, Republic of KoreaCollege of Pharmacy, Pusan National University, Busan 46241, Republic of KoreaCollege of Pharmacy, Pusan National University, Busan 46241, Republic of KoreaCollege of Pharmacy, Pusan National University, Busan 46241, Republic of KoreaCollege of Pharmacy, Pusan National University, Busan 46241, Republic of KoreaCollege of Pharmacy, Pusan National University, Busan 46241, Republic of KoreaCollege of Pharmacy, Korea University, Sejong 30019, Republic of KoreaCollege of Pharmacy, Pusan National University, Busan 46241, Republic of KoreaPolyhydroxybutyrate (PHB) has emerged as a novel material for replacing various plastics used in the medical field. However, its application as a drug-delivery carrier for colitis-targeted delivery has not been explored. In this study, we used biosynthesized PHB combined with Eudragit FS (EFS) and cyclosporine A (CSA) to develop pH-responsive controlled CSA-releasing nanoparticles (CSA-PENPs) for colitis-targeted drug delivery and demonstrated its enhanced therapeutic efficacy in a dextran sulfate sodium (DSS)-induced murine colitis model. PHB was successfully biosynthesized in the bacterium <i>Cupriavidus necator</i>, as demonstrated by <sup>1</sup>H-NMR and FT-IR analyses. CSA-PENPs were fabricated via the oil-in-water emulsion solvent evaporation method. Owing to the potent pH-responsive and sustained drug release properties provided by PHB and EFS, CSA-PENPs could deliver a sufficient amount of CSA to inflamed tissues in the distal colon; in contrast, CSA-loaded EFS nanoparticles displayed premature burst release before reaching the target site. Due to enhanced CSA delivery to colitis tissues, CSA-PENPs exhibited potent anti-inflammatory effects in the DSS-induced murine colitis model. Overall, CSA-PENPs could be a promising drug-delivery system for treating ulcerative colitis.https://www.mdpi.com/1999-4923/14/12/2811polyhydroxybutyratepH-responsiveulcerative colitiscolitis-targeted drug deliverysustained releasePHB biosynthesis
spellingShingle Juho Lee
Aruzhan Saparbayeva
Shwe Phyu Hlaing
Dongmin Kwak
Hyunwoo Kim
Jihyun Kim
Eun Hee Lee
Jin-Wook Yoo
<i>Cupriavidus necator</i>-Produced Polyhydroxybutyrate/Eudragit FS Hybrid Nanoparticles Mitigates Ulcerative Colitis via Colon-Targeted Delivery of Cyclosporine A
Pharmaceutics
polyhydroxybutyrate
pH-responsive
ulcerative colitis
colitis-targeted drug delivery
sustained release
PHB biosynthesis
title <i>Cupriavidus necator</i>-Produced Polyhydroxybutyrate/Eudragit FS Hybrid Nanoparticles Mitigates Ulcerative Colitis via Colon-Targeted Delivery of Cyclosporine A
title_full <i>Cupriavidus necator</i>-Produced Polyhydroxybutyrate/Eudragit FS Hybrid Nanoparticles Mitigates Ulcerative Colitis via Colon-Targeted Delivery of Cyclosporine A
title_fullStr <i>Cupriavidus necator</i>-Produced Polyhydroxybutyrate/Eudragit FS Hybrid Nanoparticles Mitigates Ulcerative Colitis via Colon-Targeted Delivery of Cyclosporine A
title_full_unstemmed <i>Cupriavidus necator</i>-Produced Polyhydroxybutyrate/Eudragit FS Hybrid Nanoparticles Mitigates Ulcerative Colitis via Colon-Targeted Delivery of Cyclosporine A
title_short <i>Cupriavidus necator</i>-Produced Polyhydroxybutyrate/Eudragit FS Hybrid Nanoparticles Mitigates Ulcerative Colitis via Colon-Targeted Delivery of Cyclosporine A
title_sort i cupriavidus necator i produced polyhydroxybutyrate eudragit fs hybrid nanoparticles mitigates ulcerative colitis via colon targeted delivery of cyclosporine a
topic polyhydroxybutyrate
pH-responsive
ulcerative colitis
colitis-targeted drug delivery
sustained release
PHB biosynthesis
url https://www.mdpi.com/1999-4923/14/12/2811
work_keys_str_mv AT juholee icupriavidusnecatoriproducedpolyhydroxybutyrateeudragitfshybridnanoparticlesmitigatesulcerativecolitisviacolontargeteddeliveryofcyclosporinea
AT aruzhansaparbayeva icupriavidusnecatoriproducedpolyhydroxybutyrateeudragitfshybridnanoparticlesmitigatesulcerativecolitisviacolontargeteddeliveryofcyclosporinea
AT shwephyuhlaing icupriavidusnecatoriproducedpolyhydroxybutyrateeudragitfshybridnanoparticlesmitigatesulcerativecolitisviacolontargeteddeliveryofcyclosporinea
AT dongminkwak icupriavidusnecatoriproducedpolyhydroxybutyrateeudragitfshybridnanoparticlesmitigatesulcerativecolitisviacolontargeteddeliveryofcyclosporinea
AT hyunwookim icupriavidusnecatoriproducedpolyhydroxybutyrateeudragitfshybridnanoparticlesmitigatesulcerativecolitisviacolontargeteddeliveryofcyclosporinea
AT jihyunkim icupriavidusnecatoriproducedpolyhydroxybutyrateeudragitfshybridnanoparticlesmitigatesulcerativecolitisviacolontargeteddeliveryofcyclosporinea
AT eunheelee icupriavidusnecatoriproducedpolyhydroxybutyrateeudragitfshybridnanoparticlesmitigatesulcerativecolitisviacolontargeteddeliveryofcyclosporinea
AT jinwookyoo icupriavidusnecatoriproducedpolyhydroxybutyrateeudragitfshybridnanoparticlesmitigatesulcerativecolitisviacolontargeteddeliveryofcyclosporinea